Memantine for memory protection during brain radiation
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a medicine called memantine can help protect memory and thinking skills in people getting radiation to the brain and spine. If you qualify, you would receive memantine or a placebo during your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 39 years old.
- You are scheduled to receive radiation to your brain and spine (craniospinal irradiation).
- You are able to do most daily activities on your own (like walking, playing, or going to school/work).
- You have not taken memantine before.
- You can take a memory and thinking test (like the Wechsler test).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biomarkers in your blood that might predict how radiation treatment affects brain function. The goal is to understand and possibly reduce cognitive side effects.
This trial tests whether two medications, memantine and raloxifene, can help protect memory and thinking abilities during radiation therapy for brain tumors. It is for people who are about to start or have started radiation therapy for a solid tumor in the brain.
This study tests whether two medications, memantine and pioglitazone, can help protect your memory and thinking skills during and after radiation therapy for brain tumors. It may help you keep your mental sharpness while treating the cancer.
This study tests whether a medicine called memantine combined with a structured exercise program can help protect your thinking and memory during chemotherapy for breast cancer. It may also help understand how these treatments work in the body.
This study uses MRI scans to look at how radiation treatment for newly diagnosed brain metastases affects thinking and memory. It aims to understand the effects better, which may help guide future treatment.
This study tests whether avoiding the hippocampus (a part of the brain important for memory) during whole-brain radiotherapy can slow down thinking and memory decline. It may help some people preserve neurocognitive function while still treating brain metastases.
Hear when a new Neurocognitive Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.